ment, possibly by downregulating the function and expression of adhesion molecules on the vessel wall (19, 20) . In the rat mesentery, HO-1 induction reduced leukocyte recruitment after ischemia-reperfusion (6) . Bilirubin may be responsible for decreased leukocyte recruitment, since superfusion of bilirubin largely repressed the effects of HO inhibition with zinc protoporphyrin-IX. The data of Almolki et al. (2) support this two-pronged protective mechanism of bilirubin acting as an antioxidant directly by its peroxyl radical-scavenging properties as well as by decreasing inflammatory cell recruitment during airway inflammation.
The signaling properties of CO may also contribute to the anti-inflammatory effects of HO-1. CO serves a similar role as NO in signal transduction. In addition, since CO does not contain free electrons as NO does, it is relatively inert and does not generate reactive nitrogen species as NO can. In fact, in certain settings, NO may actually be proinflammatory (10) . Thus in oxidative or inflammatory settings such as asthma, the role of HO-1 and CO may be particularly important, making CO preferentially selected over NO as a signaling molecule to activate guanylyl cyclase and regulate local blood flow. By activating this second messenger system, CO can mediate numerous physiological processes, such as activities of protein kinases, ion channels, and phosphodiesterases (9, 12) that are inherently antioxidant.
In asthma, a potentially critical role for HO-1-derived CO is its ability to relax airway smooth muscle via the activation of guanylyl cyclase and formation of cGMP (8). Almolki et al. (2) demonstrate very nicely that induction of HO-1 by hemin reduced pulmonary inflation pressure in both control and ovalbumin-challenged guinea pigs that received histamine to initiate bronchoconstriction. These data provide compelling functional evidence illustrating yet another protective role of HO-1.
The clinical significance of HO-1 during asthma is still an open question. HO-1 and its products may be useful in both diagnostic and therapeutic roles. For example, recent studies demonstrate that the level of exhaled CO is associated with the clinical severity of asthma (22) , which may be useful as a simple, noninvasive tool in assessing asthma severity (11) . CO may also serve a therapeutic role. Low-dose inhaled CO reduced both aeroallergen-induced inflammation and airway hyperresponsiveness in mice (3, 5) . Defining not only the regulation of HO-1 during airway inflammation and asthma but also diagnostic and therapeutic roles of CO and the other components of the HO-1 pathway will remain an important avenue of investigation for the foreseeable future. 
